Search Contract Opportunities

Technical Information Research Resources for Cance   3

ID: 75N98023R00012 • Type: Solicitation
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

The purpose of the acquisition is to provide a variety of critical cancer prevention information management functions
necessary to support the identification, development, and qualification of potential cancer preventive agents for
Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for clinical trials. Support
for cancer preventive agent development includes the gathering and organizing of information from the research,
pharmaceutical, and medical literature; preclinical and clinical technical project reports; scientific meetings; and private industry documents provided to the NCI under confidentiality agreements. Support also includes abstracting and maintaining databases of technical reports; abstracting application materials for the PREVENT Cancer Preclinical Drug Development Program (PREVENT); preparing specific chemical and biological agents and general class documents and structure/function and genomic/proteomic informational and statistical analyses for DCP programs;
drafting and finalizing minutes of the PREVENT meetings; and identifying and reporting potential opportunities in
cancer preventive agent development research.
Background
The purpose of the acquisition is to provide a variety of critical cancer prevention information management functions necessary to support the identification, development, and qualification of potential cancer preventive agents for Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for clinical trials. The contract is issued by the National Cancer Institute, National Institutes of Health, with the goal of supporting cancer preventive agent development through information gathering, organizing, abstracting, maintaining databases, preparing specific chemical and biological agents, drafting minutes of meetings, and identifying potential opportunities in cancer preventive agent development research.

Work Details
The tasks include technical information research resources for cancer preventive agent development. The contractor shall furnish all necessary services, qualified personnel, material, equipment, and facilities to perform the Statement of Work. This includes gathering and organizing information from research, pharmaceutical and medical literature; abstracting and maintaining databases of technical reports; preparing specific chemical and biological agents; drafting and finalizing minutes of meetings; identifying and reporting potential opportunities in cancer preventive agent development research. The contractor shall also submit various reports such as Technical Progress Reports, Quarterly Progress Reports, Annual Progress Report, Draft Final Report, Summary of Salient Results, Agent Development Information Databases. Additionally, the contractor shall comply with HHS Security and Privacy Language for Information and IT procurements.

Period of Performance
The period of performance for this contract is from 08/30/2023 through 08/29/2024. There are also options for additional periods if exercised by the government.

Place of Performance
The contract work will be performed at the National Cancer Institute, National Institutes of Health in Bethesda, MD 20892-9705.
Show All

Overview

Agency
National Institutes of Health (NIH) [HHS]
Response Deadline
May 2, 2023, 2:00 p.m. EDT Past Due
Posted
April 3, 2023, 6:14 p.m. EDT
Set Aside
Small Business (SBA)
NAICS
541690 - Other Scientific and Technical Consulting Services
PSC
R499 - Support- Professional: Other
Place of Performance
Not Provided
Source
SAM
Current SBA Size Standard
$19 Million
Pricing
Multiple Types Common
Est. Level of Competition
Average
Signs of Shaping
96% of obligations for similar contracts within the National Institutes of Health were awarded full & open.
On 4/3/23 National Institutes of Health issued Solicitation 75N98023R00012 for Technical Information Research Resources for Cance due 5/2/23. The opportunity was issued with a Small Business (SBA) set aside with NAICS 541690 (SBA Size Standard $19 Million) and PSC R499.
Primary Contact
Name
GIBAU, BRITTANY M   Profile
Email
brittany.gibau@nih.gov
Phone
+1 240 276 6863

Documents

Posted documents for Solicitation 75N98023R00012

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Solicitation 75N98023R00012

Award Notifications

Agency published notification of awards for Solicitation 75N98023R00012

Contract Awards

Prime contracts awarded through Solicitation 75N98023R00012

Incumbent or Similar Awards

Contracts Similar to Solicitation 75N98023R00012

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation 75N98023R00012

Similar Active Opportunities

Open contract opportunities similar to Solicitation 75N98023R00012

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > NATIONAL INSTITUTES OF HEALTH > NIH NCI
FPDS Organization Code
7529-00316
Source Organization Code
100188082
Last Updated
May 17, 2023
Last Updated By
mclaurinsm@mail.nih.gov
Archive Date
May 17, 2023